Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms induced nephron progenitor cells from human-induced pluripotent stem cells |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Delayed renal graft function | Preclinical | United States | 27 May 2026 | |
| Nephrosis | Preclinical | China | 03 Nov 2025 |





